This audio is automatically created. Please let me know if there is feedback.
As the popularity of eight loss drugs, such as Ozempic and Wegovy, is increasing, consumers are reconstructing the way consumers eat, and some food giants are seeing the opportunity to benefit from the transition by promoting everything from the meat. Rod and frozen meals in the soup.
About 14%of American adults have taken GLP-1 drugs to manage other diseases such as weight loss or diabetes. Drugs that suppress appetite have caused worry that food consumption and sales can decrease significantly if the popularity of these drugs increases in the food industry.
But so far, fOOD manufacturers have generally endured volume reduction.
Executives say that they are armed with protein, nutrients and other healthy properties and correspond to the demands of those who take the drug.
Conagra Brands has added more than 20 labels of the company’s healthy choice. The frozen meal is “GLP-1 friendly,”It was made into the first major food brand to call popular weight loss drugs in the packaging. The company is seeing how consumers respond to the label and collect feedback before determining whether other brands can enjoy marketing or similar labels.
Sean Connolly, CEO of Conagra Brands, told reporters at the annual consumer analyst group (CAGYY) meeting in Florida, “This is an opportunity with the companies in our space. “It is really that people really help us understand that we are here for you, we have a lot of solutions to help you achieve your goals and maintain your goals.”
Connoli said that many products from Conagra, including birds eye vegetables, slim luggage sticks full of protein, and healthy choice frozen meals are attractive to consumers using GLP-1 drugs for weight management.
Similarly, he said that these foods continue to resonate even after they stop taking drugs because they control drugs, and they contain nutrients necessary for consumers to maintain weight and health.
Conagra is alone just by targeting GLP-1 users of new products.
“This is absolutely an opportunity with the companies in our space. It is really that we really have a lot of solutions to help people understand that we are here for you. ”
Sean Connolly
CEO of the Conagra brand
General Mills is promoting Progresso High Protein and Fiber SOUP to GLP-1 users using targeted advertisents this year. Danone, the world’s largest yogurt manufacturer, has partnered with medical practitioners and retailers and marketing oikos, too good & co and other products. Solutions for those taking GLP-1 drugs.
and Last year, Nestlé started a preliminary drink. Under the boost brand that can help consumers inhibit hunger and feel full. Also released For almost 30 years, the first major American brand is called vital pursuit. For consumers taking other individuals who are focusing on GLP-1 drugs and weight management.
Laurent Freixe, the CEO of Nestlé, told Cagny’s analysts, Laurent Freixe, the world’s largest food manufacturer.
Selective caption
The authority granted by the Conagra brand
Should I worry about snacks?
Recent study Cornell University and Molecule GLP-1 users have reduced food expenditures by about 6% within 6 months after medication. It is especially difficult for products to spend on products such as chips, grilled foods, side and cookies between 6.7% to 11.1%.
Michele Buck, CEO of Hershey, is the creator of Kiss and Leeds in November. “Mild” effect of GLP-1.
However, other generous treatment manufacturers have seen something to be ignored. changeAlong with Pepsico CEO Ramon Laguarta, I did not see the “direct impact” of the GLP-1 drug last month.
Mondelēz International CEO Dirk Van de Put said Oreo and Cadbury manufacturers have recently collaborated with major consulting firms to evaluate how GLP-1 affects food consumption. They knew they had eaten smaller parts while taking the drug, but after stopping the use of the drug, they returned to the previous consumption habits.
Van de PUT said in an interview with Food Dive that GLP-1 drugs can reduce Mondelēz’s volume by up to 1.5%by 2035. He said that a large snack company does not have to make a healthier product, but there is no need to create a smaller part that people can eat while taking the drug.
Mondelēz He also has less immunity to GLP-1 than competitors, since 10 thousands of the business came from the United States.
Van de PUT said, “We are not awake from now on, between all threats we need to do in our business and the dangers we need to deal with. “This is a threat, but I don’t understand it wrong, but at this stage we don’t feel embarrassed about it. I think it’s possible to manage. ”
Britanni QuattrochiAnalysts of Edward Jones said that the driving force among shoppers toward more healthy products, cleaner ingredient profiles and functional nutrition, which had a greater impact on changing markets and innovation methods than GLP-1.
“Overall (weight loss drug) It would not have affected a wider food category. Quatrochi said: “We still haven’t seen any company coming out. ‘This is a big reason why this actually affects our business or actually struggles to grow volume.” ‘
